8-K: Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
Kiora Pharmaceuticals | DEF 14A: Definitive information statements
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Kiora Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | DEFA14A: Others
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
No Data